Carsgen Therapeutics Limited (2171.HK) Q3 2024 Earnings

28AugConfirmed
Q2 2023
Q1 2024
Q3 2024
-0.97
-0.74
-0.51
-0.28

Details

Expected EPS
-0.27897883312000005
Actual EPS
-0.67598717256
Surprise EPS
-0.4
Surprise Percent
+142.31%

Description

Carsgen Therapeutics Limited (2171.HK) has reported earnings of -0.67598717256 per share for Q3 2024.

0 Comments

Share your thoughts